Senseonics (NYSE:SENS) Shares Gap Up - Is It Still a Buy?

Senseonics Holdings, Inc. (NYSE:SENS) saw its share price rise significantly before the trading session on Thursday. The stock, which had closed the previous day at $1.17, opened at $1.23. By the conclusion of the trading day, shares were last seen at $1.29, with a total trading volume of 5,848,861 shares.

Updates on Analyst Ratings

Recent commentary from various research firms has focused on Senseonics. Notably, HC Wainwright confirmed a "buy" rating and set a price target of $2.00 for the shares in a report dated Friday, November 15. Additionally, StockNews.com launched coverage on Senseonics on Thursday, December 26, providing a "sell" rating for the company.

Current Stock Performance

As of now, Senseonics has seen its stocks decline by 5.3%. The company’s 50-day simple moving average stands at $0.73, while the 200-day simple moving average is at $0.48. In terms of liquidity, Senseonics shows a debt-to-equity ratio of 59.17, a quick ratio of 2.38, and a current ratio of 2.47.

Insider Transactions

In other news, CFO Frederick T. Sullivan made a notable investment by purchasing 124,933 shares of the company's stock on Thursday, December 12, at an average price of $0.38 each, totaling around $47,474.54. With this purchase, Sullivan now holds 2,478,844 shares in the company, estimated to be worth approximately $941,960.72, reflecting a 5.31% increase in his position. This transaction has been disclosed in an SEC filing. Furthermore, CEO Timothy T. Goodnow acquired 315,000 shares on Tuesday, December 10, at an average price of $0.31 per share, amounting to $97,650.00. Post-acquisition, Goodnow owns 11,310,355 shares valued at $3,506,210.05, marking a 2.86% increase in ownership. Currently, insiders hold 3.60% of the company’s stock.

Institutional Investors' Activities

Recent developments also indicate that several institutional investors have begun to stake positions in Senseonics. Symmetry Partners LLC entered the market by purchasing shares worth about $164,000 during the third quarter. GSA Capital Partners LLP followed suit with a new stake valued at roughly $117,000 during the same period. Moreover, FMR LLC enhanced its shareholding by 48,267.2%, now owning 168,318 shares valued at $59,000 after acquiring an additional 167,970 shares in the most recent quarter. Geode Capital Management LLC also increased its position in Senseonics by 3.2%, now holding 5,838,396 shares worth $2,042,000 after a purchase of 179,103 shares. Additionally, Ridgecrest Wealth Partners LLC made a new investment in the fourth quarter valued at approximately $60,000. Collectively, institutional investors own 12.36% of the shares in the company.

About Senseonics

Senseonics Holdings, Inc. is a medical technology enterprise specializing in the development and manufacture of continuous glucose monitoring (CGM) systems for diabetes management in the U.S. and internationally. Their product line includes Eversense, Eversense XL, and Eversense E3, which are implantable CGM systems designed to monitor glucose levels effectively using an under-skin sensor complemented by a removable and rechargeable smart transmitter and an intuitive app for real-time diabetes management.

Conclusion

As Senseonics experiences a notable uptick in share price and various insider investments, the question remains whether this health technology stock is a buy. Investors may wish to consider the differing opinions among analysts and the ongoing activities of institutional investors before making investment decisions.

Senseonics, Stock, Investing